Autoimmunity Reviews

Article	Citations
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	309
Editorial Board	189
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	153
Susac syndrome: A scoping review	148
Endometriosis and autoimmunity	118
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	112
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	97
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	96
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	88
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	85
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	84
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	78
“Fibromyalgia syndrome” related to Essure devices	78
Editorial Board	77
Editorial Board	77
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	76
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	76
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	74
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	71
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	70
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	70
Can anticoagulation be withdrawn in APS patients after aPL negativization?	65
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	63
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	61
Psychiatric manifestations of autoimmune encephalitis	60

The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	57
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	54
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	54
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	52
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	52
Editorial Board	52
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	51
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	50
Seronegative autoimmune diseases: A challenging diagnosis	48
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	48
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	46
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	45
Autoimmune pre-disease	45
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	45
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	45
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	45
Autoimmunity in vitiligo: Therapeutic implications and opportunities	44
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	44
Editorial Board	43
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	43
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	43
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	42
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	41
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	41
A descriptive study of IgG4-related disease in children and young adults	40
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	39
SpA plus IBD or IBD plus SpA: Does commutative property apply?	39
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	39
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	39
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	38
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	38
Editorial Board	38
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	37
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	37
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	37
Adipose failure through adipocyte overload and autoimmunity	37
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	36
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	35
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	35
Chronic inflammation in Long COVID relationship to autoimmune diseases	35
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	34
Tumor necrosis factor-α inhibitor-related autoimmune disorders	33
Development of an algorithm for IgG4-related disease management	33
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	32
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	32
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	32
Editorial Board	31
Fibromyalgia: Are we using the biopsychosocial model?	31
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	30
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	30

Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	30
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	29
Editorial Board	29
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	29
The role of mitochondrial dysfunction in kidney injury and disease	29
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	29
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	28
Mucous membrane pemphigoid	28
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	28
Editorial Board	28
Twenty shades of the mosaic of autoimmunity	28
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	27
Editorial Board	27
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	27
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	27
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	27
Are IF-ANA the guiding light for SLE classification in the real-world setting?	27
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	27
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review	26
Alarmins in autoimmune diseases	26
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	26
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	26
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	26
Reply letter to letter to the editor	26
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	25
Cutting edge confusion about cut-off settings in autoimmune diagnostics	25
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	25
Neuroimaging in thyroid eye disease: A systematic review	25
Editorial Board	25
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
Diagnostic approach in giant cell arteritis	24
In Memoriam: Pierre Youinou	24
Salivary gland involvement in ANCA-associated vasculitis	24
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	24
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	24
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	24
IL-33 in Spondyloarthritis, the missing key	24
Is it time for treat-to-target in antiphospholipid syndrome?	24
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	23
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials	23
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	23
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	22
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	22
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	22
Inflammatory muscle involvement in systemic vasculitis: A systematic review	22
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	22
From inflammation to renal fibrosis: A one-way road in autoimmunity?	22
Extending the discussion: Cannabis based therapies in inflammatory bowel disease a letter to the editor	22
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
JAK inhibitors and systemic sclerosis: A systematic review of the literature	22
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	21
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	21
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	21
Editorial Board	21
Serum calprotectin is a marker of disease activity in Giant cell arteritis	21
Persistent aortic inflammation in patients with giant cell arteritis	21
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	21
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	20
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	20
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Editorial Board	20
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	19
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	19
Editorial Board	19
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	19
Don't mix apples and oranges. Reply to Azoulay et al.	19
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	19
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	18
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	18
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	18
Insights into new-onset autoimmune diseases after COVID-19 vaccination	18
Intermittent fasting: A promising dietary intervention for autoimmune diseases	18
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	18
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	18
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview	18

Research advances on targeted-Treg therapies on immune-mediated kidney diseases	18
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	18
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	17
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	17
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	17
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	17
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	17
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	17
Emerging roles of mechanically activated ion channels in autoimmune disease	17
Prevention of rheumatoid arthritis using a familial predictive medicine approach	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	17
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17
Involvement of aquaporin 5 in Sjögren’s syndrome	16
Exploring vaccine safety and adverse events in major autoimmune diseases	16
Anti-glomerular basement membrane vasculitis	16
Editorial Board	16
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	15
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	15
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	15
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	15
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	15
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	15
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	15
Relapses in giant cell arteritis: Updated review for clinical practice	15
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	15
Intravenous immunoglobulin as a therapy for autoimmune conditions	15
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	15
Editorial Board	15
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	15
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	15
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	15
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	15
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	14
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	14
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation	14
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	14
Cardiovascular risk in psoriatic arthritis: How can we manage it?	14
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	14
The role of γδ T cells and CAR-γδ T cell therapy in autoimmune diseases	14
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	14
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	13
Editorial Board	13
Exposome: Epigenetics and autoimmune diseases	13
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	13
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	13
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials	13
Cognitive impairment in systemic autoimmune and inflammatory diseases: A narrative review focused on ANCA-associated vasculitis, sarcoidosis, Sjögren's syndrome, systemic sclerosis, and Behçet's disea	13
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	13
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	13
Building a monitoring matrix for the management of multiple sclerosis	13
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	13
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	13
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases	13
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	13
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	13
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	12
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	12
SLE patients with childhood-onset: A nation-wide population-based study	12
Key points to consider for an improved detection and characterization of cryoglobulins	12
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	12
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	12
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	12
Social determinants of health and disparities across the Patient pathway in Systemic Lupus Erythematosus: a narrative review	12
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	12
Residual pain in rheumatoid arthritis: Is it a real problem?	12
Editorial Board	12
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	12
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	12
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	12
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	12
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	11
Renal involvement in systemic sclerosis	11
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	11
The role of B cells in Sjögren's syndrome and their impact on the nervous system	11
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?	11
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	11
Editorial Board	11
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	11
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	11
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	11
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	11
Interleukin-6 in neuroimmunological disorders: Pathophysiology and therapeutic advances with satralizumab	11
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	11
Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation	11
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	11
Aquaporins: Unexpected actors in autoimmune diseases	11
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	11
Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease	11
Global analysis of antiphospholipid syndrome and stroke research: identifying emerging trends, international collaborations, and knowledge gaps	11
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	11
A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management	10
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment	10
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis	10